Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Shadow who wrote (3226)	10/19/1999 9:40:00 PM
From: RSH	Read Replies (1) \| Respond to of 3369

The 8-K actually lends credence to the buyout rumor Here's another news release (10-1-99) that is in the news for Epitope, Inc. but not for SALV. The V.P. of Sales, Marketing, and Chief Operations Officer (Dr. Paul Slowey) has also left SALV to join Epitope. This may also lead one to believe that a buyout may be in the very near future. It also suggests that SALV IS a credible company that doubled its sales under Dr. Slowey's direction. It may be time to accumulate more shares of SALV. biz.yahoo.com Ron